CoChat

Double‐blind placebo‐controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease

Piketty, C., Jayle, D., Leplege, A., Castiel, P., Ecosse, E., Gonzalez‐Canali, G., Sabatier, B., Boulle, N., Debuire, B., Le Bouc, Y., Baulieu, E.‐E., Kazatchkine, M. D. · 2001 · Clinical Endocrinology
Cited by 35

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVE Plasma levels of dehydroepiandrosterone sulphate (DHEA‐S) decrease with the progression of HIV disease. Here, we report on the efficacy and safety of the oral administration of DHEA as replacement therapy, in patients with advanced HIV disease, in a trial that was primarily aimed at assessing quality of life. DESIGN The trial was randomized and double‐blind. Thirty‐two patients were allocated to either DHEA 50 mg per day for 4 months (n = 14) or a matching placebo (n = 18). Clinical data, virological and immunological surrogate markers of HIV infection, plasma levels of DHEA‐S and the Medical Outcomes Study HIV Health Survey (MOS‐HIV) quality of life scale were recorded every month. RESULTS The mean age of the patients was 40 ± 11 years. The mean CD4 cell count at baseline was 32·5 ± 32·4 × 10 6/l. The mean DHEA‐S plasma level at baseline was 5·23 ± 0·76 µmol/l. No side‐effects related to DHEA occurred during the study. A statistically significant increase in the levels of DHEA‐S was observed in the treated group throughout the study (P < 0·01). A significant improvement in the Mental Health and Health Distress dimension of MOS‐HIV was observed in the DHEA treated group; P = 0·001 and 0·004, respectively. No change in CD4 cell counts was seen during follow‐up. CONCLUSIONS The administration of DHEA in patients with advanced HIV infection results in improved mental function scores as assessed by the MOS‐HIV quality of life scale.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.2001.01310.x

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 35

Metadata

Authors
Piketty, C., Jayle, D., Leplege, A., Castiel, P., Ecosse, E., Gonzalez‐Canali, G., Sabatier, B., Boulle, N., Debuire, B., Le Bouc, Y., Baulieu, E. ‐., & Kazatchkine, M. D.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2001-09
Volume
55
Issue
3
Pages
325-330
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2052875228
Cited by
35
References
5
FWCI
2.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Double‐blind placebo‐controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease. https://app.cochat.ai/papers/10.1046/j.1365-2265.2001.01310.x
The paper
Piketty, C., Jayle, D., Leplege, A., Castiel, P., Ecosse, E., Gonzalez‐Canali, G., Sabatier, B., Boulle, N., Debuire, B., Le Bouc, Y., Baulieu, E. ‐., & Kazatchkine, M. D. (2001). Double‐blind placebo‐controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.2001.01310.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.